Medicina | Free Full-Text | The Effect of Heat Shock Protein 90 Inhibitor on Pain in Cancer Patients: A Systematic Review and Meta-Analysis | HTML
Hsp90 C-Terminal Inhibitors | Encyclopedia MDPI
Targeting ErbB-2/Her-2+ Breast Cancer with HSP90 Inhibitors
Examples of Hsp90 N-terminal inhibitors in clinical trials. | Download Scientific Diagram
Hsp90 inhibitors in clinical trials. | Download Table
Hsp90 as Drug Target Against Bacterial and Fungal Infections | Bentham Science
Hsp90 inhibitors in clinical trials. | Download Table
Hsp90 inhibitors that reached various phases of clinical trials 2a.... | Download Scientific Diagram
Current HSP90 Inhibitors in Clinical Trials a | Download Table
HSP90 as a novel molecular target in non-small-cell lung cancer | LCTT
HSP90 Inhibitors as Therapy for Multiple Myeloma - Clinical Lymphoma, Myeloma and Leukemia
Impact of heat-shock protein 90 on cancer metastasis | Future Oncology
HSP (HSP90) Inhibition | HSP (HSP90) Inhibitor Review
Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer | Scientific Reports
Spotlight on 17‐AAG as an Hsp90 inhibitor for molecular targeted cancer treatment - Talaei - 2019 - Chemical Biology & Drug Design - Wiley Online Library
IJMS | Free Full-Text | HSP90 Inhibition and Modulation of the Proteome: Therapeutical Implications for Idiopathic Pulmonary Fibrosis (IPF) | HTML
Hsp90 inhibitor - Wikipedia
Ongoing clinical trials involving novel ALK-and HSP90-inhibitors in... | Download Table
Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
Inhibition of HSP90 molecular chaperones: moving into the clinic - The Lancet Oncology
Ganetespib: research and clinical development | OTT
HSP90 Inhibition Turns Up the Heat on Tumors
Current clinical trials involving HSP90 inhibitor in breast cancer | Download Scientific Diagram
Summary of Hsp90 inhibitors reaching clinical trials. | Download Scientific Diagram
Avens Publishing Group - Efficacy of the Hsp90 Inhibitors in Prostate Cancer Therapy
